Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
custodianship terminated ,merger time?,watch for disclosure,otc shows dark or defunct, d l usually has ducks in a row ,very strange seeing dark or defunct
sell now or buy and hold.no experience with this but seems they will be back and than easy 20 bagger from here.i may be willing to throw some lotto tkts at this one before delisting. will ask around if anyone else got experience with this stuff.
I mentioned this on another board, I don't believe the Halifax, Nova Scotia call center ever existed. I stopped by there not long ago. Also they did not register the business with Access Nova Scotia(except for New Brunswick companies) which is required.
Out of province businesses must register with Access Nova Scotia. https://rjsc.gov.ns.ca/rjsc/ Only one hit on the search. BIOLOGIXS INFUSION CLINIC LTD. (New Brunswick Corporation) Revoked for Non-Payment 2012-02-01
Lol. Saw this one mentioned a few times. Didn't look. Was bored the other day and looked. In tears at how this was so predictable if I had only known when the private company was being r/s into shell. Let's just say it didn't surprise me there was a public play of a stinky involved for the private company. It's a 15 year history I have with some involved Way back in time tunnel
Biologix Hair Inc. Announces Going Private Strategy, Delisting and Deregistration
Biologix Hair Inc. (OTCBB:BLGX)(OTCQB:BLGX) announced today that it will remove its common stock from quotation on the OTC Bulletin Board and deregister from the reporting requirements of the Securities Exchange Act of 1934, as amended. In light of available capital raising opportunities and recent regulatory changes, Biologix has decided to adopt a going private strategy that it believes will maximize management efficiencies and allow the Company to take advantage of new capital raising exemptions contained in the JOBS Act, which will allow registration exempt companies to raise up to $50 million in any 12-month period from accredited investors.
Both management and the Board of Directors believe that the going private strategy will protect Biologix from market instability during its crucial development stage, all while dramatically reducing capital raising and overhead costs. Biologix is eligible to deregister its stock because it has fewer than 300 shareholders of record. The going private strategy will see Biologix remove its common stock from quotation on the OTC Bulletin Board by filing a Form 25 with the SEC, whereafter its stock will cease to be quoted within 10 days. Subsequently, the Company will also file a Form 15 with the SEC to suspend its reporting requirements under Section 15(d) of the Exchange Act. Upon filing of the Form 15, the Company will no longer be obligated to file quarterly, annual or current reports with the SEC. Adoption and completion of the going private strategy is subject to formal approval of the Board of Directors, which is expected without delay.
About Biologix Hair Inc. and Biologix Hair Science Ltd.
Biologix Hair Inc. (Biologix Hair), together with its wholly owned biotechnology subsidiary, Biologix Hair Science Ltd. (TM) (BHS), is focused on realizing the full market potential for its patent-pending hair loss formula - Biologix Revive - and its demonstrated ability to prevent and reverse the effects of alopecia, which plagues hundreds of millions worldwide.
Between mid-2004 and late 2011, more than 30,000 pre-clinical-trial treatments of Biologix Revive were administered to 5,000-plus patients in South America suffering with varying degrees of alopecia, as well as people seeking preventive treatment. The participating treatment clinicians subjectively observed and reported that virtually 100% of preventive care clients continued to retain their healthy hair and an estimated 80-85% of the males and 90-plus% of the females treated for hair regeneration experienced significant regrowth of their own natural hair. And among alopecia areata patients, virtually total hair regrowth was observed in 100% of the cases. To date, no negative side effects have been reported.
BHS is currently focused on obtaining FDA approval for its breakthrough hair loss prevention and regeneration therapy and has initiated a research and development program with one of the world's leading medical research universities, the Beijing Institute of Technology (BIT). The R&D program, expected to take approximately twelve months to complete, is an important final step before formal clinical trials and the FDA approval process begins.
Additionally, on May 11, 2012, Venable LLC, the Washington-based law firm overseeing the worldwide IP and regulatory approval processes on behalf of BHS, filed a Patent Cooperation Treaty (PCT) application on behalf of BHS for Biologix Revive in Geneva, Switzerland. The PCT is an international treaty, administered by the World Intellectual Property Organization (WIPO), to which 144 countries have as of now contracted, including Canada and the United States.
Biologix management is determined to be in a ready position to capitalize on the high-margin sales potential of the Biologix Hair Therapy System(TM), if and when FDA and other major market approvals are forthcoming.
As BHS advances the regulatory approval process, Biologix Hair, together with wholly owned subsidiary companies operated by BHS, are rapidly developing a global distribution network of licensed clinicians and medical practitioners seeking to become Certified Biologix Hair Therapists(TM) and secure exclusive territorial purchasing and treatment rights for the Biologix Hair Therapy System(TM).
Biologix Hair has decided not to risk creating any potential regulatory conflicts by offering treatment outside the United States and other major high-product-margin markets until FDA approval has been granted. Therefore, the Biologix Hair Therapy System(TM) is not yet available other than to the 5,000+ patients who participated in the pre-clinical-trials conducted in South America.
This announcement is not an offer to sell any Biologix Hair Inc. ("Biologix") securities. Offers for any given security are made only through applicable offering circulars and related documents filed with the SEC pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934. Certain statements contained herein and subsequent oral statements made by and on behalf of Biologix may contain "forward-looking statements". Such forward-looking statements are identified by words such as "intends," "anticipates," "believes," "expects" and "hopes" and includes, without limitation, the development of treatment centers and approval from regulatory authorities. Forward-looking statements express our expectations or predictions of future events or results. They are not guarantees and are subject to many risks and uncertainties. There are a number of factors beyond our control that could cause actual events or results to be significantly different from those described in the forward-looking statements. Any or all of our forward-looking statements in this report or in any other public statements we make may turn out to be wrong. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise. In Canada, Europe and the United States, the Biologix treatment is not approved for use by Health Canada, EMA or the FDA. The company makes no representations that it will receive Health Canada, EMA or FDA approvals.
Biologix Hair Inc. (BLGX) Set To Launch Commercial Treatment Operations, Opening Prototype Certified Biologix Hair Therapy Center
Biologix Hair Inc. (BLGX)(BLGX) is pleased to report that the company's wholly owned subsidiary, Biologix Hair Science Ltd.™, intends to open a company-owned and -operated certified Biologix Hair Therapy Center™ in Cartagena, Colombia before the end of October, 2013.
In addition to offering Biologix's patent pending hair loss therapy commercially for the first time and enabling Biologix to start generating revenues, the treatment facility will serve as a training center for licensed clinicians who've contracted with Biologix to operate certified Biologix Hair Therapy Centers™ and a prototype for future clinics, not operated by Biologix but by these certified clinicians.
In a news release dated May 31, 2013 entitled "Biologix Hair Inc. Reports New Clinician Licensing Numbers; Network Expands to 276 Clinics in 38 Countries; Captive Patient Universe Grows 264% to 3,284,065 People" Biologix reported that as of April 30, 2013 it had contracted with 276 operating clinics located in 38 countries. The total number of existing patients treated by this international network over the past five years is 3,284,065 with the contracting clinicians estimating that 1,315,926 of these patients would be interested in either the hair loss prevention or hair loss regeneration treatment and are candidates for the Biologix Hair Therapy System
Been following this one since the merger, it's been very strong thus far, not a ton of volume but just keeps movin' on up just like George Jefferson. Not sure if someone is promoting this, I assume so, but whatever the case they have done a solid job thus far IMO.
Interesting read from the CEO, it would indicate that promotions are pretty much a given here:
What Is A Cure For Hair Loss Worth To You and Investors?
By Ron Holland
**Note you can only see the photos in the attachment. Please e-mail to the address at the bottom of the article if you would like to view the photos.
Description: R. Holland.jpgMy name is Ron Holland, but since you're reading this, you may already know me. Even so, I'll bet you don't know that I may be the first person in recorded history to move from the beach and golf resort of Hilton Head Island, South Carolina voluntarily to Toronto, Canada.
You miss 100% of the shots you don’t take. – Wayne Gretzky
Since landing here, I've come to appreciate the country’s unofficial national sport – ice hockey. Thus the above quote from one of the sport’s greatest-ever players. I thought it quite apropos – both as it relates to my own personal decision to grab the proverbial “bull by the horns” and as it relates to the opportunity I found and its possible suitability for you.
I’ve been retired for some time from the investment business after years working as the president of a broker/dealer licensed in 47 states. And up until a few weeks ago, I lived just a few steps from a warm-water beach; when not writing on financial and freedom topics, I enjoyed everything the Hilton Head resort lifestyle had to offer. Now I’m in cold Toronto, where I walk my dog in zero-degree weather instead of on a sunny beach. You might think I’m crazy to have made the move, but read on.
It All Started With My Friend Ian – Back in September of last year, I was heading down the isle of a plane far from where either of us lived, and I heard a “Hi Ron.” I wasn't expecting to meet anyone I knew on the flight, but just to my left sat Ian and his wife – except it didn’t quite look like Ian, and I wasn’t quite sure why. We exchanged the usual pleasantries, and I made my way back to my seat. I sat there for a few minutes trying to figure out what was different about him. Then I realized what it was … he used to be bald on top, but now he had a new crop of natural hair on the top of his head.
Introducing Biologix Hair Inc. - I swapped Hilton Head for Toronto because I saw the opportunity of a lifetime with a company that has developed a medical therapy for restoring natural hair growth. It produces what millions of people long for -- live, growing hair. The kind of hair that needs to be cut every week or two. And the therapy has been demonstrated to be effective for 85% of men and more than 92% of women. And that’s a record based on more than 28,000 treatments!
The company that is turning the treatment system into a business, Biologix Hair Inc., is now positioned to dominate the world market for hair restoration and also for hair-loss prevention. We – and I say "we" because I'm the company’s CEO – intend to be first to market with an innovative new hair therapy – the Biologix Hair Therapy SystemÔ – that has proven to be highly effective at reversing the effects of hair loss (alopecia) in both males and females of all ages.
First Some Thoughts On Start-up Companies
“Start-ups can be like porn in a way: they can be fun and interesting, but most of the time pretty disappointing… another analogy is a lottery ticket.” – Lorien Gabel, chief of start-up Pingg
Normally I would agree with Gabel (quoted above). Although investing in start-ups can buy you a lot of excitement, most of them end up doing absolutely nothing that's profitable. They're like buying a lottery ticket. Having won over $4,500 many years ago playing quarter slots while waiting for my wife to dress for dinner, I know you can win, but it doesn't happen often.
But on the other hand, as Apple, Amazon and other winners have shown, if you have a unique product or service that people really want and are way ahead of the competition, your odds of winning big go way up, especially if you get in early. I believe our hair therapy system is certainly unique, I've seen it work, and it totally out-delivers against the old-style competition. It's light years ahead of painful, expensive hair transplants (moving live hair from one spot to another) or topical applications (rub and pray).
We All Want To Look Younger - Do most people want to look younger and more attractive? I believe the answer is "yes." And a full head of natural, growing hair takes you a long way toward that ideal. But to date the options have been limited to painful and expensive hair transplants and topical hair growth applications that seldom produce more than wispy results and carry adverse sexual side effects for the unlucky.
The Global Hair Restoration Market Is Huge – Although most men and women want a full head of hair, by age 35, two-thirds of American men suffer some degree of hair loss, and by age 50 nearly 85% have thinning hair (male pattern baldness). Half of all women suffer from thinning hair, usually beginning after age 50.
A Historic, Ground-Floor Opportunity - How many readers wish they had invested early in a ground-floor opportunity with Apple? Or consider Peter Thiel, the co-founder of PayPal, and his $500,000 angel investment in Mark Zuckerberg’s Facebook in 2005. It is now worth better than $2 billion.
A 2012 Opportunity - I see a real cure for baldness as potentially a very profitable opportunity for early investors like myself. Of course there are risks. Delay in regulatory approval is the first one I think of. But the biggest one is something you can't measure -- the unforeseeable. That's why I took the CEO job with Biologix Hair Inc. now here in Toronto. The potential profits are so great, I want to be in a position to deal with any problems that might get in the way.
I wish I had bought gold at $400 an ounce or silver at $5.00 or bought Apple in the early years. Life is full of profitable trades if one has the foresight, opportunity and ability to act. How about oil futures at $15 a barrel, or if I had seen where the Internet or cell phones were headed? Still, timing and control are everything in investing, and as part of top management here I can use my energy and experience to make things happen. And as for timing, this is about as early as an accredited investor can get involved.
The Proposed Business Plan
Establish A Worldwide Headquarters and Center in Toronto, Canada – This has already been completed.
A Public Awareness & Educational Effort On Combating Hair Loss – Our public relations efforts will combine a regular press release schedule with public speaking efforts at free-market and Austrian economic events, investment and medical conferences and seminars, as well as direct mail, e-mail and print newsletters.
Develop Fee-For-Service Centers In Regulatory Friendly Jurisdictions – Many hair-loss suffers will wish to seek immediate treatment rather than waiting on regulatory approval in their home countries. Fortunately, some countries, including popular international travel destinations, have positioned themselves as centers for innovation by avoiding paralyzing regulation.
So we are planning to open our first clinic in Panama City by May of this year, to be followed by Mexico, Grand Cayman and the Bahamas. Then we will replicate the model in other regional markets around the world until regulatory approval is received in the U.S., Canada and Europe.\
A Global Marketing Effort – We now own an exclusive, 99-year option for the marketing rights related to the hair therapy system. This includes worldwide intellectual property rights, manufacturing rights and marketing rights. We intend to exercise this option during the period that will expand our market area from North, Central and South America to around the world.
Research & Trials – Today after almost 20 years of research and development, we have an effective hair therapy system that addresses the real causal effect of hair loss.
The Biologix team of scientists and researchers discovered that most hair follicles in baldness sufferers aren't dead. Instead, they are only dormant. The follicles, it was discovered, are encapsulated in cist-like structures that that block the normal flow of nutrients. While the entrapment continues, a follicle is incapable of producing hair of normal strength and diameter. But end the entrapment, and natural hair growth resumes.
This model has been confirmed by the academic scientific community. In early 2011, a team of scientists at the University of Pennsylvania made headlines when they announced their findings. Our team uncovered the concept approximately 12 years ago! However, being a privately funded group, the Biologix team focused on developing a cure -- a therapy to free the trapped follicles and deliver the needed formulation of minerals, nutrients and vitamins.
Because millions of people are yearning for a real cure to baldness, rescuing trapped follicles is going to be a big business.
Secure FDA Approval in the US As Well As Other Primary Markets in the EU & Asia – Biologix intends to initiate and complete formal clinical trials in the United States and several other locations – in association with a recognized top-tier university and an experienced FDA legal team. (Note: We are currently negotiating several suitable options.) Following FDA approval, we intend to develop the Biologix opportunity in other Primary Regional Markets to make our cure for hair loss and baldness available to broad segments of the world's population.
In Summary - Biologix Hair Inc. is poised to deliver the only truly effective baldness solution known. Its experienced management team is prepared to execute fully on the potential of its business plan and to capitalize on the promise of this exciting opportunity.
I hope you now understand why I moved from Hilton Head to join the management team in Toronto. I believe this is one of the most interesting and timely opportunities I’ve encountered in my lifetime.
If you agree and are an accredited investor, then consider joining our effort as we build a company to capture and maintain a leadership position in the global market for hair loss prevention and hair rejuvenation therapies.
Please contact me for more information and to follow our progress. I’ll also make sure you receive our entire business plan.
News 
Market Data 
Discover 
